article thumbnail

SCHOTT Pharma invests in RTU cartridge capacity expansion

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Credit: SCHOTT Pharma. Drug containment and delivery solutions provider SCHOTT Pharma has announced an investment of more than €100m ($114m) to expand its manufacturing capacity for sterile ready-to-use (RTU) cartridges at its site in Lukácsháza, Hungary.

Pharma 52
article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Juvenescence enhances AI drug discovery with Ro5 acquisition

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Media 52
article thumbnail

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Media 52
article thumbnail

FDA approves YolTech’s YOLT-101 for familial hypercholesterolemia

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

FDA 52
article thumbnail

EC authorises Sydnexis’ paediatric myopia treatment

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Media 52
article thumbnail

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

FDA 52